Health systems around the world are finding themselves resilient after covid-19. The old paradigms are falling. A society where health is essential is then built.
Conscients de l’attente de plus en plus importante des malades sur leur bien-vivre, nous dédions nos efforts à construire les nouvelles voies de production des médicaments, à commencer les produits de santé dérivés du cannabis. This is why we created LaFleur which determines this large-scale project . to meet the needs of patients.
Health systems around the world are finding themselves resilient after covid-19. The old paradigms are falling. A society where health is essential is then built.
Aware of the growing expectations of patients about their wellbeing, we are dedicating our efforts to building new avenues for the production of medicines, starting with cannabis-derived health products. This is why we created LaFleur, which determines this large-scale project to meet the needs of patients.
Health systems around the world are finding themselves resilient after covid-19. The old paradigms are falling. A society where health is essential is then built.
Aware of the growing expectations of patients about their wellbeing, we are dedicating our efforts to building new avenues for the production of medicines, starting with cannabis-derived health products. This is why we created LaFleur, which determines this large-scale project to meet the needs of patients.
Resources
LaFleur team is made up of a dozen qualified people (pharmacists and engineers, healthcare professionals and managers) and a network of public and private partners who work on a daily basis.
Quality
LaFleur aspires to become a producer of medical cannabis certified to pharmaceutical standards to ensure the safe manufacture of its products in order to guarantee the highest quality for patients.
Search
We have been engaged in scientific research for more than six years through our collaboration with laboratories and universities to advance the clinical applications of cannabis actives.
Support
LaFleur takes great pride in working for patients and interacting with patients and physicians. We recognize the importance of monitoring therapeutic benefits and side effects to ensure patient safety.
Resources
LaFleur team is made up of a dozen qualified people (pharmacists and engineers, healthcare professionals and managers) and a network of public and private partners who work on a daily basis.
Quality
LaFleur aspires to become a producer of medical cannabis certified to pharmaceutical standards to ensure the safe manufacture of its products in order to guarantee the highest quality for patients.
Search
We have been engaged in scientific research for more than six years through our collaboration with laboratories and universities to advance the clinical applications of cannabis actives.
Support
LaFleur takes great pride in working for patients and interacting with patients and physicians. We recognize the importance of monitoring therapeutic benefits and side effects to ensure patient safety.
Advancing the science around medical cannabis
To ensure that the therapeutic value and risks of drugs based on cannabis assets are fully understood, LaFleur supports the idea of advancing current scientific knowledge in this field.
LaFleur plans to have its own research center in order to develop its study program around cannabis.
The ambition is to create a laboratory for research and industrial production of plant-based health products.
This image is a prototype. This is not a product marketed by LaFleur. Disregard the entries.
This image is a prototype. This is not a product marketed by LaFleur. Disregard the entries.
Advancing the science around medical cannabis
Advancing the science around medical cannabis
To ensure that the therapeutic value and risks of drugs based on cannabis assets are fully understood, LaFleur supports the idea of advancing current scientific knowledge in this field.
LaFleur plans to have its own research center in order to develop its study program around cannabis.
The ambition is to create a laboratory for research and industrial production of plant-based health products.
Our communication
Our communication
Cannabis sativa Extract Induces Apoptosis in Human Pancreatic 3D Cancer Models: Importance of Major Antioxidant Molecules Present Therein
Lire la suite >
Book “Medical Cannabis”
Lire la suite >
Agrocampus Ouest and DelleD create the “AgroHealth Innovation” Chair
Lire la suite >
Stay up to date!
Health Care Professionals
Health professionals, you are doctors, pharmacists, nurses, nurses’ aides, health executive, you want to be informed about innovations around drugs and health products derived from cannabis?
Patients
Patients, would you like to be informed about therapeutic solutions based on cannabis? Subscribe to the newsletter
Researchers
Do you already act on a daily basis to advance research for patients? Pre-clinical and clinical trial development, share your projects for future collaboration.
Stay up to date!
Stay up to date!
Health Care Professionals
Health professionals, you are doctors, pharmacists, nurses, nurses’ aides, health executive, you want to be informed about innovations around drugs and health products derived from cannabis?
Patients
Patients, would you like to be informed about therapeutic solutions based on cannabis? Subscribe to the newsletter
Researchers
Do you already act on a daily basis to advance research for patients? Pre-clinical and clinical trial development, share your projects for future collaboration.
Our offers
Our offers
Do you have a taste for a challenge? Do you want to join a young and dynamic company?
As part of our development, we are looking for new dynamic and involved talents.
